English

Celularity Inc

EDGAR

CELU Current report (8-K) · filed 2026-10-29

Annual consolidated revenue for 2025: about USD 26.55M, using the latest reported figures. The previous period, 2024, was about USD 54.22M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

5.43 million USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 5432000 USD Source

Operating margin

-78%

2026 Q2 · %

Exact inputs and evidence

Operating Income: -4237000 USD Source
Revenue: 5432000 USD Source

Operating cash flow

-1.11 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: 339000 USD Source
Operating Cash Flow: 1447000 USD Source

Cash and cash equivalents: 586 thousand USD 2026-06-30 Source
Exact value

586000 USD
Long-term debt including current maturities: 17 million USD 2023-06-30 Source
Exact value

17027000 USD
Shares outstanding: 29.3 million shares 2026-06-30 Source
Exact value

29283614 shares

Reported share-count change

18.99% · 4.67 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

24610151 shares · 2025-06-30· Source
29283614 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

18.7 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Revenue: 5284000 USD · 2025-07-01 – 2025-09-30 Source
Revenue: 26550000 USD · 2025-01-01 – 2025-12-31 Source
Revenue: 22446000 USD · 2025-01-01 – 2025-09-30 Source
Revenue: 3846000 USD · 2026-01-01 – 2026-03-31 Source
Revenue: 5432000 USD · 2026-04-01 – 2026-06-30 Source

Net income

-45.9 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -23076000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -91716000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -67354000 USD · 2025-01-01 – 2025-09-30 Source
Net income: 874000 USD · 2026-01-01 – 2026-03-31 Source
Net income: 706000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-8.92 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -8151000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -3992000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -13254000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -8151000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: 1447000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: 339000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: 1447000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

161 thousand USD

2024-01-01 – 2024-12-31

Exact inputs and evidence

Capital expenditure: 39000 USD · 2024-01-01 – 2024-03-31 Source
Capital expenditure: 70000 USD · 2024-01-01 – 2024-06-30 Source
Capital expenditure: 39000 USD · 2024-01-01 – 2024-03-31 Source
Capital expenditure: 70000 USD · 2024-01-01 – 2024-09-30 Source
Capital expenditure: 70000 USD · 2024-01-01 – 2024-06-30 Source
Capital expenditure: 161000 USD · 2024-01-01 – 2024-12-31 Source
Capital expenditure: 70000 USD · 2024-01-01 – 2024-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-29.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 7 of 11 periods available· newest 2025-12-31
Operating income: 7 of 11 periods available· newest 2025-12-31
Net income: 7 of 11 periods available· newest 2025-12-31
Operating cash flow: 7 of 11 periods available· newest 2025-12-31
Capital expenditure: 6 of 11 periods available· newest 2024-12-31
Total assets: 7 of 11 periods available· newest 2025-12-31
Total liabilities: 7 of 11 periods available· newest 2025-12-31
Current assets: 7 of 11 periods available· newest 2025-12-31
Current liabilities: 7 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 7 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 7 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-51%

Prior period

USD 54.22 million

2024-01-01 – 2024-12-31
Current period

USD 26.55 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

26550000 − 54220000 = -27670000 USD

54220000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
26550000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Celularity Inc · 2025-12-31 Celularity Inc (edgar:1752828) Year-over-year change in Revenue: -27670000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1752828?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 26550000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000149315226020424/form10-k.htm#3067400 Filing: 000149315226020424 Input fundies:Revenue: 54220000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000149315226020424/form10-k.htm#3092863 Filing: 000149315226020424
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 33.82 million

Prior period

−USD 57.89 million

2024-01-01 – 2024-12-31
Current period

−USD 91.72 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-91716000 − -57892000 = -33824000 USD

-57892000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-91716000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Celularity Inc · 2025-12-31 Celularity Inc (edgar:1752828) Year-over-year change in Net income: -33824000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1752828?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -91716000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000149315226020424/form10-k.htm#1635467 Filing: 000149315226020424 Input fundies:NetIncome: -57892000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000149315226020424/form10-k.htm#1547615 Filing: 000149315226020424
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 6.85 million

Prior period

−USD 6.4 million

2024-01-01 – 2024-12-31
Current period

−USD 13.25 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-13254000 − -6401000 = -6853000 USD

-6401000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-13254000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Celularity Inc · 2025-12-31 Celularity Inc (edgar:1752828) Year-over-year change in Operating cash flow: -6853000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1752828?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -13254000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000149315226020424/form10-k.htm#1635963 Filing: 000149315226020424 Input fundies:OperatingCashFlow: -6401000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000149315226020424/form10-k.htm#1581665 Filing: 000149315226020424
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 26.55 million 100% of revenue
Cost of revenue USD 20.07 million 76% of revenue
Operating expenses USD 66.29 million 250% of revenue
Other operating costs Derived USD 1.49 million 5.6% of revenue
Operating income −USD 61.31 million −231% of revenue
Tax, interest and other Derived USD 30.41 million 115% of revenue
Net income −USD 91.72 million −345% of revenue

Cash

Operating cash flow −USD 13.25 million −50% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2019 Operating loss: operating costs were 1,349% of revenue.
2020 Operating loss: operating costs were 1,164% of revenue.
2021 Operating loss: operating costs were 611% of revenue.
2022 Operating loss: operating costs were 242% of revenue.
2023 Operating loss: operating costs were 944% of revenue.
2024 Operating loss: operating costs were 171% of revenue.
2025 Operating loss: operating costs were 331% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2019 2019-01-01 – 2019-12-31	21147000	285276000 Derived	-264129000	-52248000 Derived	-211881000	-98368000 Derived	Source 2019-01-01 – 2019-12-31: 21147000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -264129000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -211881000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -66793000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 31575000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	14278000	166203000 Derived	-151925000	56308000 Derived	-208233000	-91027000 Derived	Source 2020-01-01 – 2020-12-31: 14278000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -151925000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -208233000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -63193000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 27834000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	21335000	130394000 Derived	-109059000	-8941000 Derived	-100118000	-116299000 Derived	Source 2021-01-01 – 2021-12-31: 21335000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -109059000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -100118000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -110096000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 6203000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	17975000	43575000 Derived	-25600000	-39792000 Derived	14192000	-143112000 Derived	Source 2022-01-01 – 2022-12-31: 17975000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -25600000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: 14192000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -137876000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 5236000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	22771000	215058000 Derived	-192287000	4008000 Derived	-196295000	-39733000 Derived	Source 2023-01-01 – 2023-12-31: 22771000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -192287000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -196295000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -38685000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 1048000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	54220000	92578000 Derived	-38358000	19534000 Derived	-57892000	-6562000 Derived	Source 2024-01-01 – 2024-12-31: 54220000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -38358000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -57892000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -6401000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 161000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	26550000	87858000 Derived	-61308000	30408000 Derived	-91716000	Unavailable	Source 2025-01-01 – 2025-12-31: 26550000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -61308000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -91716000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: -13254000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 26.6M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-12-31	Revenue	21147000	Revenue: 21147000 Open source
20202020-12-31	Revenue	14278000	Revenue: 14278000 Open source
20212021-12-31	Revenue	21335000	Revenue: 21335000 Open source
20222022-12-31	Revenue	17975000	Revenue: 17975000 Open source
20232023-12-31	Revenue	22771000	Revenue: 22771000 Open source
20242024-12-31	Revenue	54220000	Revenue: 54220000 Open source
20252025-12-31	Revenue	26550000	Revenue: 26550000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-51% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Year over year	No prior comparable period	Revenue: 21147000 Open source
20202020-12-31	Year over year	-32.5%	Revenue: 14278000 Open source Revenue: 21147000 Open source
20212021-12-31	Year over year	49.4%	Revenue: 21335000 Open source Revenue: 14278000 Open source
20222022-12-31	Year over year	-15.7%	Revenue: 17975000 Open source Revenue: 21335000 Open source
20232023-12-31	Year over year	26.7%	Revenue: 22771000 Open source Revenue: 17975000 Open source
20242024-12-31	Year over year	138.1%	Revenue: 54220000 Open source Revenue: 22771000 Open source
20252025-12-31	Year over year	-51%	Revenue: 26550000 Open source Revenue: 54220000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -230.9% 2025

Net margin -345.4% 2025

Free cash flow margin -12.1% 2024

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Operating margin	-1,249%	Operating Income: -264129000 Open source Revenue: 21147000 Open source
20202020-12-31	Operating margin	-1,064%	Operating Income: -151925000 Open source Revenue: 14278000 Open source
20212021-12-31	Operating margin	-511.2%	Operating Income: -109059000 Open source Revenue: 21335000 Open source
20222022-12-31	Operating margin	-142.4%	Operating Income: -25600000 Open source Revenue: 17975000 Open source
20232023-12-31	Operating margin	-844.4%	Operating Income: -192287000 Open source Revenue: 22771000 Open source
20242024-12-31	Operating margin	-70.7%	Operating Income: -38358000 Open source Revenue: 54220000 Open source
20252025-12-31	Operating margin	-230.9%	Operating Income: -61308000 Open source Revenue: 26550000 Open source
20192019-12-31	Net margin	-1,001.9%	Net Income: -211881000 Open source Revenue: 21147000 Open source
20202020-12-31	Net margin	-1,458.4%	Net Income: -208233000 Open source Revenue: 14278000 Open source
20212021-12-31	Net margin	-469.3%	Net Income: -100118000 Open source Revenue: 21335000 Open source
20222022-12-31	Net margin	79%	Net Income: 14192000 Open source Revenue: 17975000 Open source
20232023-12-31	Net margin	-862%	Net Income: -196295000 Open source Revenue: 22771000 Open source
20242024-12-31	Net margin	-106.8%	Net Income: -57892000 Open source Revenue: 54220000 Open source
20252025-12-31	Net margin	-345.4%	Net Income: -91716000 Open source Revenue: 26550000 Open source
20192019-12-31	Free cash flow margin	-465.2%	Revenue: 21147000 Open source Operating Cash Flow: -66793000 Open source Capital Expenditure: 31575000 Open source
20202020-12-31	Free cash flow margin	-637.5%	Revenue: 14278000 Open source Operating Cash Flow: -63193000 Open source Capital Expenditure: 27834000 Open source
20212021-12-31	Free cash flow margin	-545.1%	Revenue: 21335000 Open source Operating Cash Flow: -110096000 Open source Capital Expenditure: 6203000 Open source
20222022-12-31	Free cash flow margin	-796.2%	Revenue: 17975000 Open source Operating Cash Flow: -137876000 Open source Capital Expenditure: 5236000 Open source
20232023-12-31	Free cash flow margin	-174.5%	Revenue: 22771000 Open source Operating Cash Flow: -38685000 Open source Capital Expenditure: 1048000 Open source
20242024-12-31	Free cash flow margin	-12.1%	Revenue: 54220000 Open source Operating Cash Flow: -6401000 Open source Capital Expenditure: 161000 Open source
20252025-12-31	Free cash flow margin	Not reported	Revenue: 26550000 Open source Operating Cash Flow: -13254000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -13.3M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-12-31	Operating cash flow	-66793000	Operating Cash Flow: -66793000 Open source
20202020-12-31	Operating cash flow	-63193000	Operating Cash Flow: -63193000 Open source
20212021-12-31	Operating cash flow	-110096000	Operating Cash Flow: -110096000 Open source
20222022-12-31	Operating cash flow	-137876000	Operating Cash Flow: -137876000 Open source
20232023-12-31	Operating cash flow	-38685000	Operating Cash Flow: -38685000 Open source
20242024-12-31	Operating cash flow	-6401000	Operating Cash Flow: -6401000 Open source
20252025-12-31	Operating cash flow	-13254000	Operating Cash Flow: -13254000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -6.6M 2024

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-12-31	Free cash flow	-98368000	Operating Cash Flow: -66793000 Open source Capital Expenditure: 31575000 Open source
20202020-12-31	Free cash flow	-91027000	Operating Cash Flow: -63193000 Open source Capital Expenditure: 27834000 Open source
20212021-12-31	Free cash flow	-116299000	Operating Cash Flow: -110096000 Open source Capital Expenditure: 6203000 Open source
20222022-12-31	Free cash flow	-143112000	Operating Cash Flow: -137876000 Open source Capital Expenditure: 5236000 Open source
20232023-12-31	Free cash flow	-39733000	Operating Cash Flow: -38685000 Open source Capital Expenditure: 1048000 Open source
20242024-12-31	Free cash flow	-6562000	Operating Cash Flow: -6401000 Open source Capital Expenditure: 161000 Open source
20252025-12-31	Free cash flow	Unavailable	Operating Cash Flow: -13254000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

135.5% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Liabilities / assets	73.6%	Total Liabilities: 383633000 Open source Total Assets: 521495000 Open source
20202020-12-31	Liabilities / assets	95.7%	Total Liabilities: 412295000 Open source Total Assets: 431008000 Open source
20212021-12-31	Liabilities / assets	76%	Total Liabilities: 314710000 Open source Total Assets: 414128000 Open source
20222022-12-31	Liabilities / assets	50.4%	Total Liabilities: 202165000 Open source Total Assets: 401066000 Open source
20232023-12-31	Liabilities / assets	71.5%	Total Liabilities: 102929000 Open source Total Assets: 143889000 Open source
20242024-12-31	Liabilities / assets	93.3%	Total Liabilities: 123845000 Open source Total Assets: 132682000 Open source
20252025-12-31	Liabilities / assets	135.5%	Total Liabilities: 145391000 Open source Total Assets: 107329000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.15× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Current assets / current liabilities	1.78×	Current Assets: 36806000 Open source Current Liabilities: 20635000 Open source
20202020-12-31	Current assets / current liabilities	2.7×	Current Assets: 72160000 Open source Current Liabilities: 26677000 Open source
20212021-12-31	Current assets / current liabilities	2.25×	Current Assets: 59100000 Open source Current Liabilities: 26225000 Open source
20222022-12-31	Current assets / current liabilities	0.54×	Current Assets: 33502000 Open source Current Liabilities: 62088000 Open source
20232023-12-31	Current assets / current liabilities	0.29×	Current Assets: 19793000 Open source Current Liabilities: 67298000 Open source
20242024-12-31	Current assets / current liabilities	0.38×	Current Assets: 20561000 Open source Current Liabilities: 53680000 Open source
20252025-12-31	Current assets / current liabilities	0.15×	Current Assets: 12319000 Open source Current Liabilities: 80759000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2019 2019-01-01 – 2019-12-31	−USD 211.88 million Exact value Exact value: -211881000 USD 2019-01-01 – 2019-12-31: -211881000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Celularity Inc · 2019-12-31 Celularity Inc (edgar:1752828) Net Income: -211881000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1752828/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -211881000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000121390021040814/celu-20210331.xml#308524 Filing: 000121390021040814 The citation records this snapshot. The page link may show a newer release later.	−USD 66.79 million Exact value Exact value: -66793000 USD 2019-01-01 – 2019-12-31: -66793000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Celularity Inc · 2019-12-31 Celularity Inc (edgar:1752828) Operating Cash Flow: -66793000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1752828/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -66793000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000121390021040814/celu-20210331.xml#377035 Filing: 000121390021040814 The citation records this snapshot. The page link may show a newer release later.	USD 31.58 million Exact value Exact value: 31575000 USD 2019-01-01 – 2019-12-31: 31575000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Celularity Inc · 2019-12-31 Celularity Inc (edgar:1752828) Capital Expenditure: 31575000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1752828/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 31575000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000121390021040814/celu-20210331.xml#377406 Filing: 000121390021040814 The citation records this snapshot. The page link may show a newer release later.	−USD 98.37 million Calculation and evidence -66793000 − 31575000 USD Exact free cash flow: -98368000 USD 2019-01-01 – 2019-12-31: -66793000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 31575000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Celularity Inc · 2019-12-31 Celularity Inc (edgar:1752828) Free cash flow: -98368000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1752828?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -66793000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000121390021040814/celu-20210331.xml#377035 Filing: 000121390021040814 Input fundies:CapitalExpenditure: 31575000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000121390021040814/celu-20210331.xml#377406 Filing: 000121390021040814 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 208.23 million Exact value Exact value: -208233000 USD 2020-01-01 – 2020-12-31: -208233000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Celularity Inc · 2020-12-31 Celularity Inc (edgar:1752828) Net Income: -208233000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1752828/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -208233000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000119312522158801/d350406ds1.htm#3829028 Filing: 000119312522158801 The citation records this snapshot. The page link may show a newer release later.	−USD 63.19 million Exact value Exact value: -63193000 USD 2020-01-01 – 2020-12-31: -63193000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Celularity Inc · 2020-12-31 Celularity Inc (edgar:1752828) Operating Cash Flow: -63193000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1752828/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -63193000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000119312522158801/d350406ds1.htm#3685370 Filing: 000119312522158801 The citation records this snapshot. The page link may show a newer release later.	USD 27.83 million Exact value Exact value: 27834000 USD 2020-01-01 – 2020-12-31: 27834000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Celularity Inc · 2020-12-31 Celularity Inc (edgar:1752828) Capital Expenditure: 27834000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1752828/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 27834000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000119312522158801/d350406ds1.htm#3690874 Filing: 000119312522158801 The citation records this snapshot. The page link may show a newer release later.	−USD 91.03 million Calculation and evidence -63193000 − 27834000 USD Exact free cash flow: -91027000 USD 2020-01-01 – 2020-12-31: -63193000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 27834000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Celularity Inc · 2020-12-31 Celularity Inc (edgar:1752828) Free cash flow: -91027000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1752828?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -63193000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000119312522158801/d350406ds1.htm#3685370 Filing: 000119312522158801 Input fundies:CapitalExpenditure: 27834000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000119312522158801/d350406ds1.htm#3690874 Filing: 000119312522158801 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 100.12 million Exact value Exact value: -100118000 USD 2021-01-01 – 2021-12-31: -100118000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Celularity Inc · 2021-12-31 Celularity Inc (edgar:1752828) Net Income: -100118000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1752828/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -100118000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000095017023011440/celu-20221231.htm#2329609 Filing: 000095017023011440 The citation records this snapshot. The page link may show a newer release later.	−USD 110.1 million Exact value Exact value: -110096000 USD 2021-01-01 – 2021-12-31: -110096000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Celularity Inc · 2021-12-31 Celularity Inc (edgar:1752828) Operating Cash Flow: -110096000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1752828/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -110096000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000095017023011440/celu-20221231.htm#2434887 Filing: 000095017023011440 The citation records this snapshot. The page link may show a newer release later.	USD 6.2 million Exact value Exact value: 6203000 USD 2021-01-01 – 2021-12-31: 6203000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Celularity Inc · 2021-12-31 Celularity Inc (edgar:1752828) Capital Expenditure: 6203000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1752828/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6203000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000095017023011440/celu-20221231.htm#2442827 Filing: 000095017023011440 The citation records this snapshot. The page link may show a newer release later.	−USD 116.3 million Calculation and evidence -110096000 − 6203000 USD Exact free cash flow: -116299000 USD 2021-01-01 – 2021-12-31: -110096000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 6203000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Celularity Inc · 2021-12-31 Celularity Inc (edgar:1752828) Free cash flow: -116299000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1752828?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -110096000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000095017023011440/celu-20221231.htm#2434887 Filing: 000095017023011440 Input fundies:CapitalExpenditure: 6203000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000095017023011440/celu-20221231.htm#2442827 Filing: 000095017023011440 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	USD 14.19 million Exact value Exact value: 14192000 USD 2022-01-01 – 2022-12-31: 14192000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Celularity Inc · 2022-12-31 Celularity Inc (edgar:1752828) Net Income: 14192000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1752828/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: 14192000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000149315225004313/forms-1.htm#2885426 Filing: 000149315225004313 The citation records this snapshot. The page link may show a newer release later.	−USD 137.88 million Exact value Exact value: -137876000 USD 2022-01-01 – 2022-12-31: -137876000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Celularity Inc · 2022-12-31 Celularity Inc (edgar:1752828) Operating Cash Flow: -137876000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1752828/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -137876000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000149315225004313/forms-1.htm#2726623 Filing: 000149315225004313 The citation records this snapshot. The page link may show a newer release later.	USD 5.24 million Exact value Exact value: 5236000 USD 2022-01-01 – 2022-12-31: 5236000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Celularity Inc · 2022-12-31 Celularity Inc (edgar:1752828) Capital Expenditure: 5236000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1752828/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5236000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000149315225004313/forms-1.htm#2728138 Filing: 000149315225004313 The citation records this snapshot. The page link may show a newer release later.	−USD 143.11 million Calculation and evidence -137876000 − 5236000 USD Exact free cash flow: -143112000 USD 2022-01-01 – 2022-12-31: -137876000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 5236000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Celularity Inc · 2022-12-31 Celularity Inc (edgar:1752828) Free cash flow: -143112000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1752828?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -137876000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000149315225004313/forms-1.htm#2726623 Filing: 000149315225004313 Input fundies:CapitalExpenditure: 5236000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000149315225004313/forms-1.htm#2728138 Filing: 000149315225004313 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 196.3 million Exact value Exact value: -196295000 USD 2023-01-01 – 2023-12-31: -196295000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Celularity Inc · 2023-12-31 Celularity Inc (edgar:1752828) Net Income: -196295000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1752828/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -196295000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000164117225009319/form10-k.htm#1722724 Filing: 000164117225009319 The citation records this snapshot. The page link may show a newer release later.	−USD 38.69 million Exact value Exact value: -38685000 USD 2023-01-01 – 2023-12-31: -38685000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Celularity Inc · 2023-12-31 Celularity Inc (edgar:1752828) Operating Cash Flow: -38685000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1752828/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -38685000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000164117225009319/form10-k.htm#1766598 Filing: 000164117225009319 The citation records this snapshot. The page link may show a newer release later.	USD 1.05 million Exact value Exact value: 1048000 USD 2023-01-01 – 2023-12-31: 1048000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Celularity Inc · 2023-12-31 Celularity Inc (edgar:1752828) Capital Expenditure: 1048000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1752828/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1048000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000164117225009319/form10-k.htm#1768945 Filing: 000164117225009319 The citation records this snapshot. The page link may show a newer release later.	−USD 39.73 million Calculation and evidence -38685000 − 1048000 USD Exact free cash flow: -39733000 USD 2023-01-01 – 2023-12-31: -38685000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 1048000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Celularity Inc · 2023-12-31 Celularity Inc (edgar:1752828) Free cash flow: -39733000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1752828?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -38685000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000164117225009319/form10-k.htm#1766598 Filing: 000164117225009319 Input fundies:CapitalExpenditure: 1048000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000164117225009319/form10-k.htm#1768945 Filing: 000164117225009319 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 57.89 million Exact value Exact value: -57892000 USD 2024-01-01 – 2024-12-31: -57892000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Celularity Inc · 2024-12-31 Celularity Inc (edgar:1752828) Net Income: -57892000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1752828/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -57892000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000149315226020424/form10-k.htm#1547615 Filing: 000149315226020424 The citation records this snapshot. The page link may show a newer release later.	−USD 6.4 million Exact value Exact value: -6401000 USD 2024-01-01 – 2024-12-31: -6401000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Celularity Inc · 2024-12-31 Celularity Inc (edgar:1752828) Operating Cash Flow: -6401000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1752828/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6401000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000149315226020424/form10-k.htm#1581665 Filing: 000149315226020424 The citation records this snapshot. The page link may show a newer release later.	USD 161,000 Exact value Exact value: 161000 USD 2024-01-01 – 2024-12-31: 161000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Celularity Inc · 2024-12-31 Celularity Inc (edgar:1752828) Capital Expenditure: 161000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1752828/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 161000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000149315226020424/form10-k.htm#1583044 Filing: 000149315226020424 The citation records this snapshot. The page link may show a newer release later.	−USD 6.56 million Calculation and evidence -6401000 − 161000 USD Exact free cash flow: -6562000 USD 2024-01-01 – 2024-12-31: -6401000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 161000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Celularity Inc · 2024-12-31 Celularity Inc (edgar:1752828) Free cash flow: -6562000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1752828?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6401000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000149315226020424/form10-k.htm#1581665 Filing: 000149315226020424 Input fundies:CapitalExpenditure: 161000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000149315226020424/form10-k.htm#1583044 Filing: 000149315226020424 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 91.72 million Exact value Exact value: -91716000 USD 2025-01-01 – 2025-12-31: -91716000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Celularity Inc · 2025-12-31 Celularity Inc (edgar:1752828) Net Income: -91716000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1752828/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -91716000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000149315226020424/form10-k.htm#1635467 Filing: 000149315226020424 The citation records this snapshot. The page link may show a newer release later.	−USD 13.25 million Exact value Exact value: -13254000 USD 2025-01-01 – 2025-12-31: -13254000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Celularity Inc · 2025-12-31 Celularity Inc (edgar:1752828) Operating Cash Flow: -13254000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1752828/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13254000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1752828/000149315226020424/form10-k.htm#1635963 Filing: 000149315226020424 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

53 filings · 2,604 latest values · 2,604 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001752828, 1752828, CELU, edgar:1752828

Also known as CELULARITY INC., Celularity Inc, Celularity Inc., GX Acquisition Corp.

Celularity Inc

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation